Table 2 Outcome of anti-reflux therapy over 3.3 ± 1.1 years with respect to esophagus and asthmatic symptoms
Symptom | Number of patents (percent) | Symptom score | Symptom score reduction rate,% | P-value | |
|---|---|---|---|---|---|
Pre-treatment | Post-treatment | (2-tailed) | |||
Regurgitation | 50 (87.7%) | 5.8 ± 2.0 | 1.2 ± 1.8 | 75.1 ± 35.9 | <0.001 |
Heartburn | 49 (86.0%) | 5.6 ± 2.0 | 1.1 ± 1.6 | 75.3 ± 35.8 | <0.001 |
Esophagus symptom | 50 (87.7%) | 11.3 ± 4.0 | 2.3 ± 3.2 | 75.5 ± 35.6 | <0.001 |
Cough | 46 (80.7%) | 7.3 ± 1.6 | 2.8 ± 2.5 | 58.4 ± 34.9 | <0.001 |
wheezing | 57 (100%) | 8.4 ± 1.2 | 3.8 ± 2.7 | 53.9 ± 32.4 | <0.001 |
Chest tightness | 55 (96.5%) | 8.1 ± 1.5 | 3.9 ± 2.7 | 51.9 ± 32.7 | <0.001 |
Asthmatic symptom | 57 (100%) | 22.1 ± 5.0 | 9.9 ± 7.2 | 54.3 ± 31.9 | <0.001 |